Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$227.27
Market cap
$81.84B
P/E Ratio
25.03
Dividend/share
$9.8
EPS
$9.08
Enterprise value
$169.15B
CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals,
Highlights
The debt has declined by 24% year-on-year and by 9% since the previous quarter
The company's net income rose by 11% YoY and by 3.3% QoQ
CME's P/E is 9% below its 5-year quarterly average of 27.6 but 7% above its last 4 quarters average of 23.4
Key stats
What are the main financial stats of CME
Market
Valuations
Earnings
Shares outstanding
360.09M
Market cap
$81.84B
Enterprise value
$169.15B
Price to earnings (P/E)
25.03
Price to book (P/B)
2.96
Price to sales (P/S)
14.09
EV/EBIT
38.39
EV/EBITDA
35.61
EV/Sales
29.18
Revenue
$5.8B
EBIT
$4.41B
EBITDA
$4.75B
Free cash flow
$3.49B
Per share
Balance sheet
Liquidity
EPS
$9.08
Free cash flow per share
$9.72
Book value per share
$76.75
Revenue per share
$16.13
TBVPS
$258.21
Total assets
$123.38B
Total liabilities
$95.74B
Debt
$89.1B
Equity
$27.64B
Working capital
$1.77B
Debt to equity
3.22
Current ratio
1.02
Quick ratio
1.01
Net debt/EBITDA
18.38
Margins
Efficiency
Dividend
EBITDA margin
81.9%
Gross margin
100%
Net margin
57%
Operating margin
62.8%
Return on assets
2.6%
Return on equity
11.9%
Return on invested capital
4.6%
Return on capital employed
12.1%
Return on sales
76%
Dividend yield
4.31%
DPS
$9.8
Payout ratio
107.9%
CME stock price
How has the Cme Group stock price performed over time
Intraday
0.08%
1 week
0.06%
1 month
3%
1 year
7.54%
YTD
7.92%
QTD
3%
Financial performance
How have Cme Group's revenue and profit performed over time
Revenue
$5.8B
Gross profit
$5.8B
Operating income
$3.64B
Net income
$3.3B
Gross margin
100%
Net margin
57%
The operating income is up by 15% YoY and by 4.7% QoQ
The company's net income rose by 11% YoY and by 3.3% QoQ
The gross profit has increased by 11% YoY and by 3.1% from the previous quarter
CME's revenue is up by 11% year-on-year and by 3.1% since the previous quarter
Growth
What is Cme Group's growth rate over time
Valuation
What is Cme Group stock price valuation
P/E
25.03
P/B
2.96
P/S
14.09
EV/EBIT
38.39
EV/EBITDA
35.61
EV/Sales
29.18
The EPS is up by 11% year-on-year and by 3.3% since the previous quarter
CME's P/E is 9% below its 5-year quarterly average of 27.6 but 7% above its last 4 quarters average of 23.4
CME's price to book (P/B) is 14% higher than its 5-year quarterly average of 2.6 and 10% higher than its last 4 quarters average of 2.7
CME's revenue is up by 11% year-on-year and by 3.1% since the previous quarter
The P/S is 7% higher than the last 4 quarters average of 13.2
Efficiency
How efficient is Cme Group business performance
The ROIC has soared by 53% YoY and by 12% from the previous quarter
Cme Group's return on assets has increased by 44% YoY and by 13% QoQ
Cme Group's return on equity has increased by 11% YoY and by 3.5% QoQ
Dividends
What is CME's dividend history
DPS
$9.8
Dividend yield
4.31%
Payout ratio
107.9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Cme Group financials performed over time
Cme Group's total assets is 29% more than its total liabilities
Cme Group's total liabilities has decreased by 22% YoY and by 9% QoQ
Cme Group's total assets has decreased by 18% YoY and by 7% from the previous quarter
The debt has declined by 24% year-on-year and by 9% since the previous quarter
The debt to equity has contracted by 23% YoY and by 11% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.